Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl NEW YORK, NY, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...

Daxor to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House New York, NY, April 05, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will present at...

Hemispherx Biopharma Regains Compliance with NYSE MKT Continued Listing Standards PHILADELPHIA, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) (the “Company”), announced today that, based on a notice received on September 15, 2016 from the New York Stock...

Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014 PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...

Can-Fite BioPharma Announces Clinical and Corporate Developments for Near-Term Events PETACH TIKVA, ISRAEL--(Marketwired - Oct 22, 2013) - Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...